Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 15 of 15 entries
View as:

Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Patients

Phase: N/A Priority: Normal
NCT ID: NCT02733588 Org: User:
Start: 03/31/16 End: 06/01/17 Due: 06/01/18

G-Pen™ for Hypoglycemia Rescue in T1D Patients

Phase: N/A Priority: Normal
NCT ID: NCT02423980 Org: User:
Start: 04/30/15 End: 06/30/15 Due: 06/30/16

Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D

Phase: N/A Priority: Normal
NCT ID: NCT04074317 Org: User:
Start: 08/22/19 End: 04/02/20 Due: 04/02/21

Glucagon Ready-to-Use (RTU) for Prevention of Exercise-Induced Hypoglycemia During Aerobic Exercise in Adults With T1D

Phase: N/A Priority: Normal
NCT ID: NCT03841526 Org: User:
Start: 08/22/19 End: 04/02/20 Due: 04/02/21

Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses

Phase: N/A Priority: Normal
NCT ID: NCT03490942 Org: User:
Start: 03/15/18 End: 02/10/20 Due: 02/10/21

G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03738865 Org: User:
Start: 09/27/18 End: 04/02/19 Due: 04/02/20

Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients

Phase: N/A Priority: Normal
NCT ID: NCT03091673 Org: User:
Start: 03/27/17 End: 09/27/17 Due: 09/27/18

PK/PD Study With G-Pump (Glucagon Infusion) in T1DM Patients

Phase: N/A Priority: Normal
NCT ID: NCT02081001 Org: User:
Start: 03/31/14 End: 09/30/14 Due: 09/30/15

Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02081014 Org: User:
Start: 03/31/14 End: 11/30/14 Due: 11/30/15

Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of G-Pen(TM) (Glucagon Injection) to Treat Severe Hypoglycemia

Phase: N/A Priority: Normal
NCT ID: NCT01972152 Org: User:
Start: 10/31/13 End: 02/28/14 Due: 02/28/15

Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics

Phase: N/A Priority: Normal
NCT ID: NCT02656069 Org: User:
Start: 03/15/17 End: 09/25/17 Due: 09/25/18

G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03439072 Org: User:
Start: 01/23/18 End: 05/03/18 Due: 05/03/19

Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism

Phase: N/A Priority: Normal
NCT ID: NCT05823012 Org: User:
Start: 04/21/23 End: 02/22/24 Due: 02/22/25

Glucagon Ready to Use (RTU) in Subjects With Hyperinsulinemic Hypoglycemia After Bariatric Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03770637 Org: User:
Start: 05/10/19 End: 02/26/20 Due: 02/26/21

CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism

Phase: N/A Priority: Normal
NCT ID: NCT02937558 Org: User:
Start: 10/31/16 End: 10/31/18 Due: 10/31/19